Literature DB >> 15203790

Smokers' expectancies for nicotine replacement therapy vs. cigarettes.

Laura M Juliano1, Thomas H Brandon.   

Abstract

Smokers (N=188) recruited from the local community completed a questionnaire that measured expected outcomes of using cigarettes, nicotine gum, nicotine patch, and nicotine nasal spray. Expectancy questions relating to negative affect, craving, weight, and health risks were derived from the Smoking Consequences Questionnaire-Adult. As predicted, smokers held much greater expectancies that cigarettes help control negative affect, craving, and weight relative to nicotine replacement therapy (NRT). All NRT products were expected to cause fewer health risks than cigarette smoking. As predicted, smokers held strong negative affect reduction expectancies for cigarette smoking. For NRT, although still relatively low, craving reduction was the strongest expectancy. Individuals who had experience using the nicotine patch had greater positive expectancies for NRT. Greater positive expectancies for NRT were correlated with more immediate plans to quit smoking. In summary, cigarette smokers' positive expectancies about cigarettes do not appear to generalize to NRT products, which may limit their use and effectiveness.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15203790     DOI: 10.1080/14622200410001696574

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  17 in total

1.  E-cigarettes and expectancies: why do some users keep smoking?

Authors:  Paul T Harrell; Vani N Simmons; Barbara Piñeiro; John B Correa; Nicole S Menzie; Lauren R Meltzer; Marina Unrod; Thomas H Brandon
Journal:  Addiction       Date:  2015-08-18       Impact factor: 6.526

2.  User identified positive outcome expectancies of electronic cigarette use: A concept mapping study.

Authors:  Eric K Soule; Sarah F Maloney; Mignonne C Guy; Thomas Eissenberg; Pebbles Fagan
Journal:  Psychol Addict Behav       Date:  2017-03-09

3.  Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers).

Authors:  Paul T Harrell; Nicole S Marquinez; John B Correa; Lauren R Meltzer; Marina Unrod; Steven K Sutton; Vani N Simmons; Thomas H Brandon
Journal:  Nicotine Tob Res       Date:  2014-08-28       Impact factor: 4.244

4.  The development and psychometric evaluation of the Smokeless Tobacco Expectancies Scale (STES).

Authors:  Joshua C Gottlieb; Lee M Cohen; Kenneth G Demarree; Hayley R Treloar; Denis M McCarthy
Journal:  Psychol Assess       Date:  2013-04-01

5.  Predictors of medication adherence and smoking cessation among smokers under community corrections supervision.

Authors:  Karen L Cropsey; C Brendan Clark; Erin N Stevens; Samantha Schiavon; Adrienne C Lahti; Peter S Hendricks
Journal:  Addict Behav       Date:  2016-10-23       Impact factor: 3.913

6.  Hospitalized smokers' expectancies for electronic cigarettes versus tobacco cigarettes.

Authors:  Peter S Hendricks; Mallory G Cases; Christopher B Thorne; JeeWon Cheong; Kathleen F Harrington; Connie L Kohler; William C Bailey
Journal:  Addict Behav       Date:  2014-09-28       Impact factor: 3.913

7.  Transdermal nicotine during cue reactivity in adult smokers with and without anxiety disorders.

Authors:  Sandra B Morissette; Suzy Bird Gulliver; Barbara W Kamholz; David A Spiegel; Stephen T Tiffany; David H Barlow
Journal:  Psychol Addict Behav       Date:  2012-06-11

8.  Smokers' Treatment Expectancies Predict Smoking Cessation Success.

Authors:  Lisa M Fucito; Benjamin A Toll; Corey R Roos; Andrea C King
Journal:  J Smok Cessat       Date:  2014-08-27

9.  Mood, nicotine, and dose expectancy effects on acute responses to nicotine spray.

Authors:  Kenneth A Perkins; Amy Grottenthaler; Melinda M Ciccocioppo; Cynthia A Conklin; Michael A Sayette; Annette S Wilson
Journal:  Nicotine Tob Res       Date:  2009-04-07       Impact factor: 4.244

10.  Cigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum.

Authors:  William L Kelemen; Erika K Fulton
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.